The Management of Chronic Pain in Important Patient Subgroups

@article{Cherubino2012TheMO,
  title={The Management of Chronic Pain in Important Patient Subgroups},
  author={P. Cherubino and Piercarlo Sarzi-Puttini and Stefano Maria Zuccaro and Roberto F Labianca},
  journal={Clinical Drug Investigation},
  year={2012},
  volume={32},
  pages={35-44}
}
Chronic pain is a major healthcare issue in Europe and globally, and inadequate or undertreated pain significantly reduces the ability of many patients to participate in ordinary daily activities, adversely affects their employment status and contributes to a substantial rate of depression and anxiety in patients with chronic pain. There is a broad distinction of chronic pain into chronic non-cancer pain and chronic cancer pain, and important subgroups of these include patients with rheumatic… 
The impact of pain on systemic rheumatic diseases.
[NON-PHARMACOLOGICAL PAIN MANAGEMENT OF RHEUMATIC DISEASES].
TLDR
A small number of systematic reviews indicates the need to develop new high-quality randomized controlled trials in order to enable real insight into the effectiveness of non-pharmacological methods for the treatment of rheumatic pain.
Opioids Resistance in Chronic Pain Management
TLDR
For a better control of chronic pain a deeper knowledge of the molecular mechanisms underlying resistance to opiates is mandatory.
Pain in rheumatoid arthritis: a critical review.
TLDR
It is necessary to record a patients medical history in detail, perform a physical examination, and objectively assess synovitis and joint damage in order to ensure effective treatment stratification.
Pain in rheumatic diseases: how relevant is it?
TLDR
Most rheumatologists receive little formal training concerning contemporary theories of pain processing or management, and this may affect the clinical results of any specific target therapy.
Immunoglobulin g for the treatment of chronic pain: report of an expert workshop.
TLDR
IgG may reduce pain in a range of nociceptive and neuropathic chronic pain conditions, including diabetes mellitus, Sjögren's syndrome, fibromyalgia, complex regional pain syndrome, post-polio syndrome, and pain secondary to pathological autoantibodies.
Opioid use for Chronic Pain Management in Italy: Results from the Orthopedic Instant Pain Survey Project
TLDR
Physicians’ fear of side effects showed poor knowledge of strategies for effective management of opioid-related adverse events, such as combined oral prolonged-release oxycodone/naloxone and Continuing educational programs could improve delivery of evidence-based pain management.
Can Medical Cannabis Therapies be Cost-Effective in the Non-Surgical Management of Chronic Knee Pain?
TLDR
The study showed that MC may be a cost-effective strategy in the management of chronic knee pain; however, the evidence on the medical use of cannabis is limited and predominantly low-quality.
A mixed methods study of chronic pain in Qatar
TLDR
Chronic pain does not necessarily have a significant negative impact on all domains of quality of life, and socially connected, religiously oriented and observant people with chronic pain were able to maintain or enhance some domains of their HRQOL.
Precision medicine: the emerging approach to the chronic pain patient
TLDR
As the pain community embraces the accumulation of genomic data, it is worthwhile analyzing the caveats of a pure gene-derived approach and consider the many environmental factors that affect the highly complex phenomenon of pain.
...
...

References

SHOWING 1-10 OF 58 REFERENCES
Heterogeneity of Chronic Pain
  • R. Vellucci
  • Medicine, Psychology
    Clinical Drug Investigation
  • 2012
TLDR
Evaluation of chronic pain requires a clear understanding of the nature of the pain and its underlying pathophysiology, and adequate assessment of pain, using validated tools, is an essential prerequisite of successful pain management.
Update on guidelines for the treatment of chronic musculoskeletal pain
TLDR
New guidelines, formulated in response to recent developments concerning COX-2 inhibitors and other NSAIDs, focus on paracetamol as the baseline drug for chronic pain management; when greater analgesia is desired, the addition of weak opioids is recommended based on a preferable GI and cardiovascular profile, compared with non-steroidal anti-inflammatory drugs.
Responsible Prescribing of Opioids for the Management of Chronic Pain
TLDR
Clinical trials are needed to define the role of opioid therapy in chronic non-cancer pain, and to establish criteria for patient selection and specific treatment algorithms, to maximise pain relief and maintain tolerability.
Management of Chronic Nonmalignant Pain with Nonsteroidal Antiinflammatory Drugs
TLDR
Evidence‐based use of NSAIDs for frequently encountered pain syndromes, with special focus on the adverse effects of this class of agents is evaluated by members of the Ambulatory Care, Cardiology, and Pain and Palliative Care Practice and Research Networks of the American College of Clinical Pharmacy.
Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention
TLDR
An algorithm for musculoskeletal pain is presented emphasising a stepwise pharmacological approach in combination with an array of non-pharmacological therapies and the potential role of opioid agents in carefully selected patients.
The management of persistent pain in older persons.
  • A. Persons
  • Medicine
    Journal of the American Geriatrics Society
  • 2002
TLDR
This guideline was developed and written under the auspices of the American Geriatrics Society (AGS) Panel on Persistent Pain in Older Persons and approved by the AGS Board of Directors on April 8, 2002.
The Management of Persistent Pain in Older Persons
TLDR
This guideline was developed and written under the auspices of the American Geriatrics Society (AGS) Panel on Persistent Pain in Older Persons and approved by the AGS Board of Directors on April 8, 2002.
Opioid therapy for treating rheumatoid arthritis pain.
TLDR
There is limited evidence that weak oral opioids may be effective analgesics for some patients with RA, but adverse effects are common and may offset the benefits of this class of medications.
Prevalence of undertreatment in cancer pain. A review of published literature.
TLDR
Nearly one of two patients with cancer pain is undertreated, the percentage is high, but consists of a large variability of undertreatment across studies and settings.
Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact
TLDR
It is clear that chronic pain has a dramatic impact on European society and the lack of data in this area clearly underlines the need for decision makers in healthcare to gather further epidemiological data.
...
...